Posted in | News | Plastics and Polymers

BASF To Change Butanediol Value Chain and Plasticizers Business

BASF is to discontinue the production of diethylhexylphthalate (DEHP) and the associated alcohol 2-ethylhexanol (2-EH) in Europe in the third quarter of 2005. The 2-EH plant in Ludwigshafen, which has an annual capacity of 200,000 metric tons per year, will be shut down and dismantled beginning in October 2005.

At the same time BASF plans to close down several production facilities at its site in Feluy, Belgium, where the company no longer considers it possible to competitively manufacture phthalic anhydride, plasticizers, fumaric acid and butanediol derivatives. Maleic anhydride will, however, continue to be produced at the site. This move is being planned in view of the stagnation of European markets, excess capacities around the world, and the unfavorable cost structure of the Feluy site.

European producers and customers have increasingly been replacing the plasticizer DEHP with alternative products, in particular with C9 and C10 phthalates. This has caused the DEHP market to decrease by 50 percent since 2000.

BASF therefore offers its customers innovative plasticizer products: For standard applications the well-known Palatinol® N (DINP) and, as sole supplier, the C10 plasticizer Palatinol® 10P (DPHP). For sensitive applications such as toys, medical devices and food contact BASF offers Hexamoll® DINCH – a highly innovative plasticizer specially developed for sensitive human-contact applications.

The restructuring in Europe will have no effect on BASF’s plasticizer portfolio in NAFTA and Asia, where the company will continue to offer 2-EH and DEHP.

http://www.basf.com

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.